Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Meningococcal Disease”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT01272180
What this trial is testing

Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults

Who this might be right for
Invasive Meningococcal Disease
Novartis Vaccines 484
Testing effectiveness (Phase 2)Study completedNCT00134719
What this trial is testing

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 1,104
Large-scale testing (Phase 3)Study completedNCT00617760
What this trial is testing

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Who this might be right for
Neisseria Meningitidis (Bacterial Meningitis)Invasive Pneumococcal Disease (IPD)
Pfizer 330
Not applicableUnknownNCT04594785
What this trial is testing

Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection

Who this might be right for
Streptococcus PneumoniaStreptococcus Pyogenes InfectionNeisseria Meningitides Meningitis
University Hospital, Montpellier 150
Testing effectiveness (Phase 2)Study completedNCT05082285
What this trial is testing

A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 724
Not applicableStudy completedNCT03798574
What this trial is testing

The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults

Who this might be right for
Meningococcal InfectionsNeisseria Meningitis SepsisNeisseria Infection
University of Adelaide 98
Testing effectiveness (Phase 2)Study completedNCT00127855
What this trial is testing

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 409
Large-scale testing (Phase 3)Study completedNCT04502693
What this trial is testing

Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 3,657
Not applicableUnknownNCT05981599
What this trial is testing

Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease

Who this might be right for
Meningococcal Infections
Poitiers University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Not applicableUnknownNCT04184336
What this trial is testing

Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada

Who this might be right for
Invasive Meningococcal Disease
Canadian Paediatric Society 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT05087056
What this trial is testing

Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 312
Large-scale testing (Phase 3)Study completedNCT04318548
What this trial is testing

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 945
Testing effectiveness (Phase 2)Study completedNCT01732627
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections+1 more
Sanofi Pasteur, a Sanofi Company 301
Not applicableStudy completedNCT00450632
What this trial is testing

Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection

Who this might be right for
Meningococcal Infections
University Hospital, Rouen 101
Testing effectiveness (Phase 2)Ended earlyNCT04645966
What this trial is testing

A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants

Who this might be right for
Meningococcal Vaccine
Pfizer 326
Post-approval studies (Phase 4)Study completedNCT03694405
What this trial is testing

Adolescent MenACWY Booster Study

Who this might be right for
Meningococcal Disease, Invasive
Canadian Immunization Research Network 244
Testing effectiveness (Phase 2)Study completedNCT04886154
What this trial is testing

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,440
Large-scale testing (Phase 3)Study completedNCT00443846
What this trial is testing

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

Who this might be right for
Meningitis, MeningococcalRotavirus Infections
Merck Sharp & Dohme LLC 247
Post-approval studies (Phase 4)Study completedNCT01129518
What this trial is testing

Can we Reduce the Number of Vaccine Injections for Children?

Who this might be right for
Invasive Meningococcal Disease
University of Oxford 404